SCHEMBL3070091

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3079008	0.91	AR (0.47)	ARSMN1; SMN2MAPTTP53POLB
	SCHEMBL3076734	0.91	AR (0.50)	ARKMT2AALDH1A1KDM4EHPGD
	SCHEMBL3081229	0.91	AR (0.50)	ARPOLBALDH1A1KDM4ELMNA
	SCHEMBL3086046	0.90	AR (0.46)	ARPOLBALDH1A1NSD2TSHR
	SCHEMBL3086188	0.89	AR (0.53)	ARSMN1; SMN2KMT2AMEN1ALDH1A1
	SCHEMBL3070012	0.89	AR (0.50)	ARSMN1; SMN2MAPTPOLBKMT2A
	SCHEMBL3086122	0.88	AR (0.46)	ARSMN1; SMN2KMT2AMEN1ALDH1A1
	SCHEMBL3070135	0.87	HTT (0.46)	ARMAPTPOLBHTTPGR
	SCHEMBL3063842	0.87	AR (0.48)	ARPOLBKDM4ENSD2TSHR
	SCHEMBL3077429	0.86	AR (0.50)	ARSMN1; SMN2MAPTTP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.